| Aug 10, 2014
| 5:00 AM
Amanda Greene relies on lidocaine patches to help manage the chronic pain that her Lupus causes.
The anesthetic is available as a generic drug, typically sold at a substantially lower price. But this year, the 47-year-old Culver City resident says she's...
| Aug 11, 2014
| 9:51 AM
Less than two months after receiving approval for an inhalable form of insulin, MannKind Corp. agreed to license the drug to Paris-based Sanofi in a deal that could provide the Valencia company with $925 million.
Sanofi will initially pay MannKind $150...
| Aug 2, 2014
| 5:00 AM
It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
| Aug 4, 2014
| 9:11 PM
There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
| Aug 5, 2014
| 9:30 PM
Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
| Sep 15, 2014
| 7:08 AM
Major U.S. poultry firms are administering antibiotics to their flocks far more pervasively than regulators realize, posing a potential risk to human health.
Internal records examined by Reuters reveal that some of the nation's largest poultry producers...
| Sep 8, 2014
| 12:06 PM
The Federal Trade Commission has filed suit against North Chicago-based AbbVie and a partner, alleging the companies illegally blocked consumer access to generic versions of the testosterone replacement drug AndroGel in order to reap hundreds of...
| Jul 14, 2014
| 5:34 PM
In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...
| Apr 8, 2014
| 6:48 PM
A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos.
The jury in Lafayette,...
| Apr 11, 2014
| 10:30 PM
Twenty-five years after scientists first identified the hepatitis C virus, doctors are declaring victory over an infection that afflicts more than 3 million Americans and kills more of them than HIV.
In a series of clinical trial results, a new...
| Feb 12, 2014
| 8:33 PM
Nova Southeastern University is expanding its role in research, building a new $80 million facility that could boost South Florida's efforts to become a hub for studies of cancer, heart disease and other problems.
The Center for Collaborative Research,...